Timothy Noyes's Email & Phone

Timothy P. Noyes joined Proteon Therapeutics in 2006 as the company's President and CEO, bringing more than 16 years of knowledge and experience in drug development and bringing products to market. Previously, Mr. Noyes was Chief Operating Officer of Trine Pharmaceuticals, where he held broad general management responsibility across all functional areas relating to drug development, including preclinical, clinical, manufacturing, regulatory, marketing and business development. Prior to joining Trine in 2002, Mr. Noyes held several management and leadership roles with GelTex Pharmaceuticals, prior to its acquisition by Genzyme Corporation. After the acquisition, he held the position of President, Renal Division and President, GelTex Pharmaceuticals. He also worked for several years with Merck & Co. across multiple roles in its hypertension and heart failure group, managed care division, and on its Vasotec and Prilosec products. Mr. Noyes is a graduate of Harvard College, and holds a master's in business administration from the Harvard Business School.